Figure 4.
Neutralisation of EBOV (Mayinga) GP pseudotyped (a) HIV-1 and (b) VSV by EVD survivor and negative plasma samples. The IC50 of pseudotyped virus neutralisation were estimated by model of nonlinear regression dose–response curves. Data are shown for individuals and the geometric mean with 95% confidence interval (95% CI). Dotted lines represent background level of neutralisation. Background level of pseudotyped HIV-1 neutralisation (IC50 6.28 reciprocal dilution) is equal to UK negative control plasma mean plus two standard deviations, n = 7. Background level of pseudotyped VSV neutralisation is equal to the lowest dilution of sample tested in the assay (1/20). Statistically significant differences are highlighted (**p < 0.01, ****p < 0.0001; Mann–Whitney).